• Title/Summary/Keyword: Saos-2 cell

검색결과 25건 처리시간 0.193초

JPH203, a selective L-type amino acid transporter 1 inhibitor, induces mitochondria-dependent apoptosis in Saos2 human osteosarcoma cells

  • Choi, Dae Woo;Kim, Do Kyung;Kanai, Yoshikatsu;Wempe, Michael F.;Endou, Hitoshi;Kim, Jong-Keun
    • The Korean Journal of Physiology and Pharmacology
    • /
    • 제21권6호
    • /
    • pp.599-607
    • /
    • 2017
  • Most normal cells express L-type amino acid transporter 2 (LAT2). However, L-type amino acid transporter 1 (LAT1) is highly expressed in many tumor cells and presumed to support their increased growth and proliferation. This study examined the effects of JPH203, a selective LAT1 inhibitor, on cell growth and its mechanism for cell death in Saos2 human osteosarcoma cells. FOB human osteoblastic cells and Saos2 cells expressed LAT1 and LAT2 together with their associating protein 4F2 heavy chain, but the expression of LAT2 in the Saos2 cells was especially weak. JPH203 and BCH, a non-selective L-type amino acid transporter inhibitor, potently inhibited L-leucine uptake in Saos2 cells. As expected, the intrinsic ability of JPH203 to inhibit L-leucine uptake was far more efficient than that of BCH in Saos2 cells. Likewise, JPH203 and BCH inhibited Saos2 cell growth with JPH203 being superior to BCH in this regard. Furthermore, JPH203 increased apoptosis rates and formed DNA ladder in Saos2 cells. Moreover, JPH203 activated the mitochondria-dependent apoptotic signaling pathway by upregulating pro-apoptotic factors, such as Bad, Bax, and Bak, and the active form of caspase-9, and downregulating anti-apoptotic factors, such as Bcl-2 and Bcl-xL. These results suggest that the inhibition of LAT1 activity via JPH203, which may act as a potential novel anti-cancer agent, leads to apoptosis mediated by the mitochondria-dependent intrinsic apoptotic signaling pathway by inducing the intracellular depletion of neutral amino acids essential for cell growth in Saos2 human osteosarcoma cells.

Overexpression of TTRAP inhibits cell growth and induces apoptosis in osteosarcoma cells

  • Zhou, Caihong;Shen, Qi;Xue, Jinglun;Ji, Chaoneng;Chen, Jinzhong
    • BMB Reports
    • /
    • 제46권2호
    • /
    • pp.113-118
    • /
    • 2013
  • TTRAP is a multi-functional protein that is involved in multiple aspects of cellular functions including cell proliferation, apoptosis and the repair of DNA damage. Here, we demonstrated that the lentivirus-mediated overexpression of TTRAP significantly inhibited cell growth and induced apoptosis in osteosarcoma cells. The ectopic TTRAP suppressed the growth and colony formation capacity of two osteosarcoma cell lines, U2OS and Saos-2. Cell apoptosis was induced in U2OS cells and the cell cycle was arrested at G2/M phase in Saos-2 cells. Exogenous expression of TTRAP in serum-starved U2OS and Saos-2 cells induced an increase in caspase-3/-7 activity and a decrease in cyclin B1 expression. In comparison with wild-type TTRAP, mutations in the 5'-tyrosyl-DNA phosphodiesterase activity of TTRAP, in particular $TTRAP^{E152A}$, showed decreased inhibitory activity on cell growth. These results may aid in clarifying the physiological functions of TTRAP, especially its roles in the regulation of cell growth and tumorigenesis.

Saos-2 골육종 세포에서 iron chelating agent, deferoxamine에 의한 apoptosis 유도 (Iron chelating agent, deferoxamine, induced apoptosis in Saos-2 osteosarcoma cancer cells)

  • 박은혜;이효정;이수연;김선영;이호근;이대열;황평한
    • Clinical and Experimental Pediatrics
    • /
    • 제52권2호
    • /
    • pp.213-219
    • /
    • 2009
  • 목 적:철은 세포 성장과 분화, 전자 전달 반응, 산소 전달, 해독작용 등 여러 가지 중요한 생체 반응에 반드시 필요한 요소로서 종양세포의 성장과 증식에도 절대적으로 필요하다. 최근에 철킬레이트제인 deferoxamine이 악성 구강 각질세포의 성장을 억제하고 세포자멸사를 유도하며, 난소암세포의 증식을 억제하고 세포자멸사를 유도하여 난소암의 성장을 억제하였다고 보고되었다. 그러므로 반복적인 수혈에 의하여 헤모시데린침착증이 발생한 소아 종양 환아에서 deferoxamine이 철을 제거 할 뿐만 아니라 암세포의 세포자멸사를 유도하는지에 대하여 알아보고 세포자멸사를 유도한다면 그 경로에 대하여 알아보고자 하였다. 방 법:골육종세포인 Saos-2에서 deferoxamine에 대한 효과를 알아보기 위하여 크리스탈 바이올렛과 트리판 블루 염색으로 세포의 성장 및 증식을 측정하였고, DNA 분획, 핵 응축, 세포주기분석으로 세포자멸사를 분석하였고, 세포자멸사와 관련된 분자들의 발현을 Western hybridization으로 분석하였다. 결 과:Deferoxamine은 Saos-2 세포에 대하여 시간과 농도에 의존적으로 세포 증식 억제 효과를 나타내었다. 이러한 세포 증식 억제 효과는 DNA 단편화, 핵 응축, 세포주기 분석에서의 $A_{0}$ 기의 증가, PARP의 활성도의 증가 등 세포자멸사가 유도되었음을 알 수 있었다. 또한 Saos-2 세포에서 deferoxamine 처리 후 Akt/PKB의 활성화가 억제되어 caspase 9의 활성화, 그 하류의 caspase 3의 활성화로 이어지는 미토콘드리아 매개되는 경로로 세포자멸사가 유도되었다. 결 론:결론적으로 철킬레이트제인 deferoxamine이 세포증식을 억제시키고 세포자멸사를 유도시킴으로써 골육종 세포의 증식을 억제하는 것을 보여주었다. 따라서 반복적 대량 수혈에 의한 철 과부하에 따른 장기손상이 우려되는 각종 소아 종양환자들에서 deferoxamine은 체내 축적된 철을 제거할 뿐만 아니라 종양 환자의 치료에 있어서 항암제 치료의 효과를 증가시킬 수 있는 새로운 치료법으로 개발될 수 있을 것이다.

레스베라트롤에 의한 골육종 Saos-2 세포의 세포고사 (Resveratrol Induces the Apoptosis of Osteosarcoma Saos-2 Cells)

  • 이현장;양재현;최익준;최이천;김용권;임창인;윤재도;김호찬;원진숙
    • Toxicological Research
    • /
    • 제18권3호
    • /
    • pp.259-265
    • /
    • 2002
  • Resveratrol, a phytoalexin found in grapes, berries, and peanuts, is one of the most promising agents for cancer prevention. Recent studies show that the antitumor activity of resveratrol occurs through p53-mediated apoptosis. This study demonstrated the mechanism that resveratrol induced apoptosis in human osteosarcoma Saos-2 cells lacking p53. Treatment of osteosarcoma Saos-2 cells with resveratrol resulted in decrease of cell viability, which was revealed as apoptosis characterized by activation of caspase-3 protease as well as cleavage of poly(ADP-ribose) polymerase (PARP) with change of mitochondrial membrane potential transition. These results suggest that resveratrol may be potentially useful to treat osteosarcoma via activation of caspase protease and mitochondrial dysfunction.

사람 골육종 세포 Saos2에서 아미노산 수송계 L의 발현 및 기능적 특성 (EXPRESSION AND FUNCTIONAL CHARACTERIZATION OF AMINO ACID TRANSPORT SYSTEM L IN SAOS2 HUMAN OSTEOGENIC SARCOMA CELLS)

  • 김수관;김현호;김창현;김도경
    • Journal of the Korean Association of Oral and Maxillofacial Surgeons
    • /
    • 제32권3호
    • /
    • pp.200-208
    • /
    • 2006
  • Amino acids are required for protein synthesis and energy sources in all living cells. The amino acid transport system L is a major nutrient transport system that is responsible for $Na^+$-independent transport of neutral amino acids including several essential amino acids. In malignant tumors, the L-type amino acid transporter 1 (LAT1), the first isoform of system L, is highly expressed to support tumor cell growth. In the present study, the expression and functional characterization of amino acid transport system L were, therefore, investigated in Saos2 human osteogenic sarcoma cells. RT-PCR and western blot analyses have revealed that the Saos2 cells expressed the LAT1 and the L-type amino acid transporter 2 (LAT2), the second isoform of system L, together with their associating protein heavy chain of 4F2 antigen (4F2hc) in the plasma membrane, but the expression of LAT2 was very weak. The uptakes of [${14}^C$]L-leucine by Saos2 cells were $Na^+$-independent and were completely inhibited by the system L selective inhibitor, 2-aminobicyclo-(2,2,1)-heptane-2-carboxylic acid (BCH). The affinity of [${14}^C$]L-leucine uptake and the inhibition profiles of [${14}^C$]L-leucine uptake by various amino acids in the Saos2 cells were comparable with those for the LAT1 expressed in Xenopus oocytes. The majority of [${14}^C$]L-leucine uptake is, therefore, mediated by LAT1 in the Saos2 cells. These results suggest that the transports of neutral amino acids including several essential amino acids into Saos2 human osteogenic sarcoma cells are for the most part mediated by LAT1. Therefore, the Saos2 human osteogenic sarcoma cells are excellent tools for examine the properties of LAT1. Moreover, the specific inhibition of LAT1 in tumor cells might be a new rationale for anti-tumor therapy.

miRNA-218 Inhibits Osteosarcoma Cell Migration and Invasion by Down-regulating of TIAM1, MMP2 and MMP9

  • Jin, Jie;Cai, Lin;Liu, Zhi-Ming;Zhou, Xue-Song
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제14권6호
    • /
    • pp.3681-3684
    • /
    • 2013
  • Deregulated miRNAs participate in osteosarcoma genesis. In this study, the expression of miRNA-218 in human osteosarcomas, adjacent normal tissues and Saos-2 human osteosarcoma cells was first assessed. Then the precise role of miRNA-218 in osteosarcoma cells was investigated. Upon transfection with a miR-218 expression vector, the proliferation of Saos-2 human osteosarcoma cells determined using the ATPlite assay was significantly suppressed, whilw migration of Saos-2 cells detected by wound healing and invasion determined using transwells were dramatically inhibited. Potential target genes of miR-218 were predicted and T-cell lymphoma invasion and metastasis 1 (TIAM1) and matrix metalloproteinase 2 (MMP2) and 9 (MMP9) were identified. This was confirmed by western blotting, which showed that miR-218 expression inhibited TIAM1, MMP2 and MMP9 protein expression. Collectively, these data suggest that miR-218 acts as a tumor suppressor in osteosarcomas by down-regulating TIAM1, MMP2 and MMP9 expression.

Saos-2 세포에서 Doxorubicin에 의한 세포사멸 유도과정에서의 유전자 발현 변화 (Profile of Gene Expression Changes During Doxorubicin Induced Apoptosis of Saos-2)

  • 임정숙;배민재;백석환;김재룡;김정희;김성용
    • Journal of Yeungnam Medical Science
    • /
    • 제22권2호
    • /
    • pp.221-240
    • /
    • 2005
  • 사람의 악성 골종양 세포주 Saos-2 를 이용하여 doxorubicin에 의해 발현이 증가 또는 감소하는 유전자들의 변화를 cDNA microarray를 이용하여 확인하였다. 그 결과 대조군에 비하여 2배 이상 증가 또는 감소하는 유전자 264개, 3배 이상 증가 또는 감소하는 유전자 35개를 선별할 수 있었다. Doxorubicin 처리 후 시간대 별로 발현변화가 비슷한 유전자들을 k-mean clustering으로 분석하여 5가지의 군으로 분류할 수 있었다. A군은 24시간 까지 계속 발현이 증가하는 67개 유전자, B군은 6시간까지는 변화가 없다가 24시간에는 감소하는 108개 유전자, C군은 6시간에 발현의 감소하고 24시간까지 지속되는 33개 유전자, D군은 6시간에 발현의 감소하였으나 24시간에는 다시 발현이 회복되는 5개 유전자, 그리고 E군은 6시간까지는 발현의 변화가 없다가 24시간에 발현이 증가하는 경향을 보이는 51개 유전자로 구분하였다. cDNA microarry 결과 발현차이가 현저한 22개의 유전자들을 대상으로 RT-PCR을 시행하여 발현정도를 비교하였다. cDNA microarry에서 발현증가를 보이는 13개 유전자 중에서, RT-PCR 결과 11개가 그 발현이 증가하였으며, cDNA microarry의 결과에서 발현감소를 보이는 9개 유전자 중에서 RT-PCR 결과에서 2개 유전자만 감소하였다. 이상의 결과 Saos-2 세포에서 doxorubicin에 의해 세포사멸과 세포성장, 세포신호전달, 세포골격, 세포주기, 운반, 대사 등에 관여하는 많은 유전자들의 발현이 변함을 확인할 수 있었다.

  • PDF

Astragali Radix extract as a therapeutics on osteoporosis

  • Kim, Chung-Sook;Ha , Hye-Kyung;Song, Kye-Yong
    • 대한약학회:학술대회논문집
    • /
    • 대한약학회 2002년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.2
    • /
    • pp.387.1-387.1
    • /
    • 2002
  • Aging and estrogen cleficiency after menopause induce bone loss and result in osteoporosis. This study was investigated effects of n-hexane fraction (Hx) extracted from Astragali Radix on osteoporosis with osteoblast-like cell line (MG-63 and Saos-2) and an ovariectomized (OVX) rat model. Proliferation of osteoblast-like cells. MG-63 and Saos-2. was tested with MTT and alkaline phosphatase (ALP) assays. (omitted)

  • PDF

마그네슘 티타네이트 표면의 조골세포 부착도와 분화 (Osteoblast adhesion and differentiation on magnesium titanate surface)

  • 최승민;이재관;고성희;엄흥식;장범석
    • Journal of Periodontal and Implant Science
    • /
    • 제35권4호
    • /
    • pp.851-861
    • /
    • 2005
  • The nature of the implant surface can directly influence cellular response, ultimately affecting the rate and quality of new bone tissue formation. The aim of this in vitro study was to investigate if human osteoblast-like cells, Saos-2, would respond differently when plated on disks of magnesium titanate and machined titanium. Magnesium titanate disks were prepared using Micro Arc Oxidation(MAO) methods. Control samples were machined commercially pure titanium disks. The cell adhesion, proliferation and differentiation were evaluated by measuring cell number, and alkaline phosphatase(ALPase) activity at 1 day and 6 day after plating on the titanium disks. Measurement of cell number and ALPase activity in Saos-2 cells at 1 day did not demonstrate any difference between machined titanium and magnesium titanate. When compared to machined titanium disks, the number of cells was reduced on the magnesium titanate disks at 6 day, while ALPase activity was more pronounced on the magnesium titanate. Enhanced differentiation of cells grown on magnesium titanate samples was indicated by decreased cell proliferation and increased ALPase activity.